“With community infection rate still stubbornly high, there is ample opportunity yet for another variant with higher case fatality rate to emerge before the proposed autumn campaign – and if it does perhaps this advice may yet be regretted, given that it’s a long time to wait for autumn,” said Prof Penny Ward, visiting professor in pharmaceutical medicine at King’s College London.
